Real-world clinical data, put to work
Mycoach isn’t a demo. It’s embedded in clinical practice today — and the proof is in the publications, the trials, and the depth of disease coverage it already supports.
Figures are platform-reported aggregates across deployed sites, as of 2026.
A platform clinicians publish from
The fastest way to judge a clinical data platform is to ask what came out of it. From Mycoach: peer-reviewed science, multi-center trials, and competitive research funding — all drawn from structured real-world data.
30 peer-reviewed publications
Impact factors up to 66.8 and 650+ cumulative citations, co-authored with clinical partners.
12 multi-center clinical trials
The platform serves as the structured-data backbone across its hospital network.
Competitive research funding
Studies built on the platform have attracted national and provincial research grants since 2021.
10+ specialties, 20+ diseases
In production across neurology, cardiology, oncology, rheumatology and more.
Deep in neuromuscular disease
We go vertical before we go wide. Our anchor is neuromuscular disease — where continuous, quantified tracking matters most, and where we built a first-of-its-kind assessment.
Myasthenia gravis
A first-of-its-kind AI assessment of disease severity (QMG), bringing objective, quantified tracking out of the clinic.
ALS · SMA · CMT
Coverage extends across motor-neuron and inherited neuromuscular conditions that demand longitudinal data.
Expanding by specialty
The same structured foundation extends into new specialties through existing hospital partnerships.
Backed, incubated & recognised
Incubated at Hong Kong Science & Technology Parks, backed through CityU’s HK Tech 300, and co-developing an AI health-assistant pilot for Hong Kong citizens.
See your clinical data, structured.
Book a 30-minute walkthrough with our clinical team and bring a sample workflow.